Chihiro Mitsui

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.

Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.

Journal: The Journal of allergy and clinical immunology

Published: November 28, 2022

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.

Journal: American journal of respiratory and critical care medicine

Published: March 07, 2020

Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.

Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: April 26, 2019

A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations.

A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: April 03, 2019

De novo sensitization to Aspergillus fumigatus in adult asthma over a 10-year observation period.

De novo sensitization to Aspergillus fumigatus in adult asthma over a 10-year observation period.

Journal: Allergy

Published: March 20, 2018

Th1-related disease development during omalizumab treatment: Two cases with severe asthma.

Th1-related disease development during omalizumab treatment: Two cases with severe asthma.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: August 03, 2017

DIFFERENCES IN FRACTION OF EXHALED NITRIC OXIDE VALUES MEASURED BY TWO HAND-HELDED ANALYZERS (NObreath® AND NIOX Vero®).

DIFFERENCES IN FRACTION OF EXHALED NITRIC OXIDE VALUES MEASURED BY TWO HAND-HELDED ANALYZERS (NObreath® AND NIOX Vero®).

Journal: Arerugi = [Allergy]

Published: May 19, 2017

A CASE OF BRONCHIAL ASTHMA WITH HYPEREOSINOPHILIA WITH EFFECTIVE SAIBOKUTOU THERAPY.

A CASE OF BRONCHIAL ASTHMA WITH HYPEREOSINOPHILIA WITH EFFECTIVE SAIBOKUTOU THERAPY.

Journal: Arerugi = [Allergy]

Published: May 19, 2017

THE FRACTION OF EXHALED NITRIC OXIDE (FENO) AND FORCED OSCILLATION TECHNIQUE (FOT) CAN PREDICT BRONCHIAL HYPERRESPONSIVENESS AGAINST ACETYLCHOLINE IN TREATED ASTHMATICS.

THE FRACTION OF EXHALED NITRIC OXIDE (FENO) AND FORCED OSCILLATION TECHNIQUE (FOT) CAN PREDICT BRONCHIAL HYPERRESPONSIVENESS AGAINST ACETYLCHOLINE IN TREATED ASTHMATICS.

Journal: Arerugi = [Allergy]

Published: February 21, 2017

Advances in aspirin-exacerbated respiratory disease (AERD).

Advances in aspirin-exacerbated respiratory disease (AERD).

Journal: Nihon rinsho. Japanese journal of clinical medicine

Published: October 01, 2016

Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers.

Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 02, 2016

Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease.

Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease.

Journal: The Journal of allergy and clinical immunology

Published: August 15, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026